Explore
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0
0 Ungluers have
Faved this Work
Login to Fave
Cardiovascular diseases (CVDs) continue to be the leading cause of mortality worldwide, with an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Heart attacks and strokes accounted for approximately 85% of these fatalities The prevalence of CVDs is worsened by metabolic diseases, particularly diabetes, which affects about 422 million people globally, primarily in low- and middle-income countries, and causes 1.5 million deaths annually. Early detection and intervention of CVDs and metabolic diseases are crucial, as many cases can be prevented by addressing modifiable behavioral risk factors such as tobacco use, unhealthy diet, obesity, physical inactivity, and harmful alcohol consumption. Significant advancements in treatment, from pharmacological developments to both invasive and non-invasive techniques, are continuously being made. Given the complexity and clinical significance of this topic, Biomedicines is proud to present a Special Issue titled "Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0". This issue aims to compile contemporary scientific information on emerging treatments for CVDs and metabolic diseases. They provide valuable insights to the field and enhance our understanding of these interconnected health challenges.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 3 times via unglue.it ebook links.
- 3 - pdf (CC BY-NC-ND) at Unglue.it.
Keywords
- 4-hydroxyphenyllactic acid
- acute myocardial infarction
- adenotonsillectomy
- Adolescents
- aortic aneurism
- aortic dissection
- aortic valve
- aromatic microbial metabolites
- Atrial Fibrillation
- bexagliflozin
- biomarkers
- Blood pressure
- Calcification
- Cancer
- cardiac macrophages
- Cardiac Remodeling
- Cardiac Surgery
- cardiac tissue
- cardiovascular
- Cardiovascular Disease
- Cardiovascular Diseases
- cardiovascular prevention
- cardiovascular risk
- cardiovascular surgery patients
- carotid endarterectomy
- carotid stenosis
- Children
- cognitive training
- conventional risk factors
- coronary disease
- CPAP
- CVDs
- Diabetes Mellitus
- Diet
- echocardiography
- electrical cardioversion
- emerging risk factors
- evolocumab
- exosomal RNA sequencing
- exosome
- fatty liver index
- fibroblast growth factor 23
- glucagon-like peptide-1 receptor agonist
- handgrip
- Heart Failure
- heart valve replacement
- Herbs
- infectious complications
- Inflammation
- isometric strength
- kidney macrophages
- left ventricular diastolic dysfunction
- lipoprotein(a)
- low T3 syndrome
- metabolic syndrome
- microRNA
- multi-tasking
- muscle strength dynamometer
- Myocardial Infarction
- n/a
- NIV adherence
- noninvasive ventilation
- obesity hypoventilation syndrome
- obstructive sleep apnea
- orthotopic heart transplantation (OHT)
- orthotopic liver transplantation
- osteopontin
- PCSK9
- PCSK9 inhibitor
- pharmaceutical drugs
- platelet
- post-procedural complications
- postoperative cognitive dysfunction
- Proteomics
- real-life
- Remodeling
- Sleep Apnea
- sodium-glucose cotransporter-2 inhibitors
- sodium/glucose cotransporter 2 (SGLT2) inhibitors
- Stroke
- thema EDItEUR::M Medicine and Nursing
- thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
- thyroid hormone
- thyroid receptors
- transcatheter aortic valve implantation (TAVI)
- transfusion
- Treatment
- two-dimensional speckle-tracking echocardiography
- tyrosine metabolites
- vascular stiffness
- women’s health
Links
DOI: 10.3390/books978-3-7258-1668-2Editions